The DOI matches its Crossref record.
The non‐peptide tachykinin antagonist, CP‐96,345, is a potent inhibitor of neurogenic inflammation
Open accessAbstract
Release of the tachykinin, substance P, from the peripheral terminals of polymodal afferent C‐fibres is thought to be largely responsible for the vasodilatation and plasma protein extravasation described as neurogenic inflammation. The effects of CP‐96,345, a non‐peptide antagonist at the substance P (NK 1) receptor, on these vascular reactions were investigated in the rat. Intravenously (i.v.) injected CP‐96,345 (0.4–3.0 μmol kg−1) prevented the drop in blood pressure, a measure of the peripheral vasodilatation, evoked by substance P and neurokinin A in a dose‐ and time‐dependent manner, but did not affect that elicited by the non‐tachykinin peptides calcitonin gene‐related peptide and vasoactive intestinal polypeptide. Plasma protein extravasation evoked by i.a. infusion of substance P, antidromic stimulation of the saphenous or the vagus nerve, and stimulation of cutaneous afferent nerves with mustard oil, were each significantly inhibited by CP‐96,345 (3.0–9.0 μmol kg−1, i.v.). Furthermore, CP‐96,345 was orally active in blocking mustard oil‐induced plasma extravasation with an ED 50 of 10 μmol kg−1. The inhibition of substance P‐induced vasodilatation and of neurogenic plasma extravasation by CP‐96,345 was stereospecific as the inactive isomer CP‐96,344 (2 R, 3 R enantiomer of CP‐96,345) had no effect. Thus CP‐96,345 is a specific, highly potent, long‐acting and orally active inhibitor of tachykinin‐mediated neurogenic inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inflammatory and immune pathways in the pathogenesis of periodontal disease
Cekici, A., Kantarci, A., Hasturk, H., & Van Dyke, T. E. (2014) · Periodontology 2000 · doi:10.1111/prd.12002 · Cited by 1,415
“Accordingly, edema induced by substance P is primarily caused by increased vascular permeability mediated through its action on neurokinin 1 receptors on endothelial cells (136).”
BackgroundTachykinin receptors and tachykinin receptor antagonists
Maggi, C. A., Patacchini, R., Rovero, P., & Giachetti, A. (1993) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1993.tb00396.x · Cited by 636
The mammalian tachykinin receptors
Maggi, C. A. (1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(94)00292-u · Cited by 486
Peptides and the primary afferent nociceptor
Levine, J., Fields, H., & Basbaum, A. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02273.1993 · Cited by 485
Maggi, C. A. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(94)e0017-b · Cited by 470
Metadata
- Authors
- Lembeck, F., Donnerer, J., Tsuchiya, M., & Nagahisa, A.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1992-03
- Volume
- 105
- Issue
- 3
- Pages
- 527-530
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2009936187
- Cited by
- 185
- References
- 0
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The non‐peptide tachykinin antagonist, CP‐96,345, is a potent inhibitor of neurogenic inflammation. https://app.cochat.ai/papers/10.1111/j.1476-5381.1992.tb09013.x
- The paper
- Lembeck, F., Donnerer, J., Tsuchiya, M., & Nagahisa, A. (1992). The non‐peptide tachykinin antagonist, CP‐96,345, is a potent inhibitor of neurogenic inflammation. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1992.tb09013.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.